Best evidence topic report. Intravenous magnesium in chronic obstructive pulmonary disease.
A short cut review was carried out to establish whether the addition of intravenous magnesium to standard treatments improved outcome in patients with exacerbations of COPD. Altogether 465 papers were found using the reported search, of which one presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of this best paper are tabulated. A clinical bottom line is stated.
Jenner
Rachel
R
Department of Emergency Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
Body
Richard
R
D000368:Aged; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008274:Magnesium / Q000008:administration & dosage*; D008297:Male; D016896:Treatment Outcome
D001993:Bronchodilator Agents; D008274:Magnesium